Log In Home    Contact


  • Canada's Government and the Bill & Melinda Gates Foundation have committed major new funding to support the Canadian HIV Vaccine Initiative.
      Press Release »     Backgrounder »

  • The European and Developing Countries Clinical Trials Partnership (EDCTP) and the Bill & Melinda Gates Foundation launch a 20 M Euro call to develop HIV vaccine trial capacity in Africa.   Press Release »   Call for Proposals »

  • The AIDS Vaccine Advocacy Coalition (AVAC) releases its 2006 report, AIDS Vaccines: The Next Frontiers   Full Report »   Press Release »

  • The International AIDS Vaccine Initiative (IAVI) launches the AIDS Vaccine Blueprint 2006 at a press briefing August 15, 2006 at the XVI International AIDS Conference in Toronto.   2006 Blueprint »

  • Peter Singer discusses the Enterprise and "Canada's role in the fight against AIDS" in an August 9, 2006 editorial in Canada's National Post.   Editorial »

  • The Bill & Melinda Gates Foundation announces 16 grants totaling $287 million to create an international network of highly collaborative research consortia to help address research priorities identified in the Scientific Strategic Plan of the Global HIV Vaccine Enterprise.   Press Release »   Backgrounder »

  • The Center for HIV-AIDS Vaccine Immunology (CHAVI), a significant component to the Global HIV Vaccine Enterprise, announces a pioneering collaboration among U.S., European, and Australian researchers.   Press Release »

  • The AIDS Vaccine Advocacy Coalition (AVAC) announces the launch of its new AIDS Vaccine Clearinghouse, a comprehensive and interactive source of AIDS vaccine information on the Internet. The website, www.aidsvaccineclearinghouse.org, provides a gateway to information and a link to people and organizations interested in AIDS vaccine advocacy, research and global delivery.

  • The U.S. National Institute of Allergy and Infectious Diseases (NIAID) selects Dr. Barton Haynes of Duke University to lead the Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium.   Press Release »

  • Bill Gates addresses the World Health Assembly in May 2005 and mentions the importance of the efforts of the Enterprise.   Full Speech »


August 2006
  • "Partnerships for the Future: AIDS Vaccine Research in the Developing World"--Affiliated event at the XVI International AIDS Conference in Toronto.
    Event announcement »

October 2005
  • The Enterprise's first Funders' Forum took place October 31-November 1, 2005, hosted by the Wellcome Trust, London.   Full Summary »   Brief Summary »

September 2005
  • An Enterprise roundtable session was held September 7, 2005, at the AIDS Vaccine 2005 conference in Montreal.

July 2005
  • Kaisernetwork.org webcast the Global HIV Vaccine Enterprise satellite session on July 25, 2005, at the International AIDS Society Conference on HIV Pathogenesis and Treatment in Brazil.   View Webcast »   (scroll down to "Satellite Symposium")

May 2005
  • The Enterprise's first Stakeholders' Forum was held in London on May 23-24, 2005, organized by the U.K. Department for International Development and the Bill & Melinda Gates Foundation.   Forum Summary »   View Video »

Executive Director Search

The Global HIV Vaccine Enterprise has engaged Heidrick & Struggles, a retained international executive recruitment firm, to assist in the search for an Executive Director.

The Enterprise and its Executive Director have the unique charge to facilitate the collaboration of scientists, companies, donors, and other organizations in the public and private sectors to accelerate the development of an HIV vaccine. We seek an experienced, dynamic and diplomatic leader who will build the permanent Secretariat and provide leadership for the Enterprise's mission to help guide and fund HIV vaccine research and development. As the primary spokesperson for the Enterprise, the Executive Director will be a major voice, authority, and champion in support of the global efforts to develop an HIV vaccine. He/she will communicate the vision and mission of the Enterprise, serve as a credible broker to create and facilitate key scientific collaborations, and catalyze public and private support to advance the development of a successful HIV vaccine.

Click here to view a detailed Position Specification and information regarding who to contact for further information.

© 2005 Global HIV Vaccine Enterprise Privacy Policy    Terms & Conditions    View Enterprise Brochure